Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T14:12:08.914Z.
Calculation as of: 2026-10-06T14:12:08.914Z.
Quote observation: 2026-10-06T14:09:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 786381cf23009ce26769892c1927912581314c354aa2592277191dd3add0e379
PEG RATIO
N/A
GridAI Technologies Corp.
Market Cap
$28.81M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| GridAI Technologies Corp. (GRDX) | $28.81M | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.03M | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.67M | N/A |
| CervoMed Inc. (CRVO)vs › | $29.63M | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.86M | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.46M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.23M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.46M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.62M | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.84M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
